EQUILLIUM, INC. Debt Securities, Available-for-sale
EQUILLIUM, INC. (EQ) had Debt Securities, Available-for-sale of $0 as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-03-25
- 2025-12-31: Debt Securities, Available-for-sale $0.00.
- 2025-09-30: Debt Securities, Available-for-sale $0.00.
- 2025-06-30: Debt Securities, Available-for-sale $0.00.
- 2025-03-31: Debt Securities, Available-for-sale $0.00.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |